Nicotine for health recovery

Nicotine is a cessation aid, not a recovery tonic: it helps some smokers quit, but the evidence here says nothing about using it to heal anything else.

The retrieved studies all concern smoking cessation, not health recovery. That is the first honest limit: nothing here tests nicotine for wound healing, cognition, or general recovery. What the evidence does show is modest. A meta-analysis of 12 trials found nicotine replacement roughly doubled the odds of long-term abstinence versus placebo, about 292 of 2,384 treated smokers abstaining versus 169 of 2,408 controls [1]. One randomized trial with 22-month follow-up reported gum users abstaining at 27.2% versus 5.7% for advice-only controls [3]. But relapse is the norm: a 1-year follow-up of 550 clinic patients found 51.4% relapsed, and pharmacotherapy type made no significant difference [2]. Most ex-smokers in one survey quit cold turkey, without any support [4].

The harms are real and underweighted here. Nicotine promotes pathological blood-vessel growth through endothelial receptors, implicated in atherosclerosis, tumor growth, and abnormal eye vessel formation in animal models [5]. That is a mechanism of harm, not a scare story. The retrieval contains no long-term safety data on nicotine use for recovery, and no study comparing nicotine users to genuinely untreated people for any health outcome. The evidence base is narrow, mostly industry-adjacent cessation research with surrogate endpoints like self-reported abstinence [2].

My call: nicotine has a modest, proven role only in smoking cessation, with a documented pro-angiogenesis harm profile; there is no evidence here supporting it for health recovery, and the burden of proof for that use has not been met. Confidence: moderate for cessation benefit, not clear for any recovery claim.